Claudia Ferroni

10PUBLICATIONS
36CO-AUTHORS
Medicinal and biomolecular chemistry not elsewhere classifiedCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 14, 2025
Correction: Momoli et al. The Evolution of Anticancer 3D In Vitro Models: The Potential Role of Machine Learning and AI in the Next Generation of Animal-Free Experiments. Cancers 2025, 17, 700.

Carolina Momoli, Beatrice Costa, Lorenzo Lenti

|Feb 26, 2025
The Evolution of Anticancer 3D In Vitro Models: The Potential Role of Machine Learning and AI in the Next Generation of Animal-Free Experiments.

Carolina Momoli, Beatrice Costa, Lorenzo Lenti

|Aug 10, 2022
Correction to "Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents".

Antonino Nicolò Fallica, Carla Barbaraci, Emanuele Amata

|Mar 26, 2022
Two Beats One: Osteosarcoma Therapy with Light-Activated and Chemo-Releasing Keratin Nanoformulation in a Preclinical Mouse Model.

Elisa Martella, Barbara Dozza, Claudia Ferroni

|Feb 25, 2022
HSA-Binding Prodrugs-Based Nanoparticles Endowed with Chemo and Photo-Toxicity against Breast Cancer.

Valentina Rapozzi, Francesca Moret, Luca Menilli

|Aug 28, 2021
Pheophorbide A and Paclitaxel Bioresponsive Nanoparticles as Double-Punch Platform for Cancer Therapy.

Francesca Moret, Luca Menilli, Manuele Battan

Pageof 2

Frequent Collaborators

9 joint publications

Greta Varchi

3 joint publications

Elisa Martella

3 joint publications

Daniele Tedesco

2 joint publications

Giovanna Sotgiu